Skip to main content
SpringerLink
Log in

T-Lymphocyte subpopulations in multiple sclerosis —Do they help to judge immunosuppressive therapy?

  • Original Articles
  • Published:
European archives of psychiatry and neurological sciences Aims and scope Submit manuscript

Summary

T-cell subpopulations were tested in multiple sclerosis (MS) patients before and after cyclophosphamide (n = 38) and corticotropin (n = 37) treatment and physiotherapy (n = 30). There were no specific changes of subset ratios immediately after immunosuppressive treatment. However, T-cell subpopulations showed great day-to-day variations in MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bach MA, Phan-Dinh-Tuy F, Tournier E, Chatenoud L, Bach JF (1980) Deficit of suppressor T cells in active multiple sclerosis. Lancet 11:1221–1223

    Google Scholar 

  2. Bach MA, Martin C, Cesaro P, Eizenbaum JF, Degos JD (1985) T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases. J Neuroimmunol 7:331–343

    Google Scholar 

  3. Brinkman CJJ, Nillesen WM, Hommes OR (1984) The effect of cyclophosphamide on T lymphocytes and T lymphocyte subsets in patients with chronic progressive multiple sclerosis. Acta Neurol Scand 69:90–96

    Google Scholar 

  4. Gonsette RE, Demonty L, Delmotte P (1977) Intensive immunosuppression with cyclophosphamide in multiple sclerosis. J Neurol 214:173–181

    Google Scholar 

  5. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EI, Weiner HL (1985) In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 312:1405–1411

    Google Scholar 

  6. Hauser SL, Dawson SM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL (1983) Intensive immunosuppression in progressive multiple sclerosis — a randomized three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 308:173–180

    Google Scholar 

  7. Kirchbach A von, Kornhuber HH (1987) T-LymphozytenSubpopulationen in Multiple-Sklerose-Patienten unter Immunsuppressionstherapie. Psycho 13:396

    Google Scholar 

  8. Kornhuber HH, Mauch E (1986) Immunsuppressive Cyclophosphamidtherapie der Multiplen Sklerose mit wenig Nebenwirkungen. Dtsch Med Wochenschr 46:1778

    Google Scholar 

  9. Kuś J, Vedal S, Kijek K, Chan-Yeung M (1984) Absence of day to day variation in lymphocyte subpopulations in healthy humans. Allergol et Immunopathol 12:407–409

    Google Scholar 

  10. McDonald WI, Halliday AM (1979) Diagnosis and classification of multiple sclerosis. Br Med Bull 33:4–8

    Google Scholar 

  11. McIntosh KR, Segre M, Segre D (1982) Characterization of cyclophosphamide-induced suppressor cells. Immunopharmacology 4:279–289

    Google Scholar 

  12. Mickey MR, Ellison GW, Fahey JL, Moody DJ, Myers LW (1987) Correlation of clinical and immunologic states in multiple sclerosis. Arch Neurol 44:371–375

    Google Scholar 

  13. Paterson PY, Drobish DG (1969) Cyclophosphamide: effect on experimental allergic encephalomyelitis in lewis rats. Science 165:191–192

    Google Scholar 

  14. Paty DW, Kastrukoff LF (1985) Suppressor T cells in multiple sclerosis: do changes in numbers vary with clinical activity? Ann NY Acad Sci 436:266–270

    Google Scholar 

  15. Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF (1980) Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med 303:125–129

    Google Scholar 

  16. Sigel MM, Huggins EM, Wood DM, Ghaffar A (1984) Selective action of cyclophosphamide on T and B cell activity. Prog Clin Biol Res 161:241–248

    Google Scholar 

  17. Thompson AJ, Brazil J, Whelan CA, Martin EA, Hutchinson M, Feighery C (1986) Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse? J Neurol Neurosurg Psychiatry 49:905–912

    Google Scholar 

  18. Tjernlund U, Cesaro P, Tournier E, Degos JD, Bach JF, Bach MA (1984) T cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function. Clin Immunol Immunopathol 32:185–197

    Google Scholar 

  19. Varkila K, Hurme M (1983) The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro. Immunology 48:433–438

    Google Scholar 

  20. Weiner HL, Hauser SL, Hafler DA, Fallis RJ, Lehrich JR, Dawson DM (1985) The use of cyclophosphamide in the treatment of multiple sclerosis. Ann NY Acad Sci 436:373–381

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Neurology, University of Ulm, D-7900, Ulm, Germany

    A. Henneberg & H. H. Kornhuber

  2. Abteilung Pathology, RWTH-Klinikum, Pauwelsstrasse, D-5100, Aachen, Germany

    E. G. Fischer

Authors
  1. A. Henneberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. G. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. H. Kornhuber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henneberg, A., Fischer, E.G. & Kornhuber, H.H. T-Lymphocyte subpopulations in multiple sclerosis —Do they help to judge immunosuppressive therapy?. Eur Arch Psychiatr Neurol Sci 238, 94–96 (1988). https://doi.org/10.1007/BF00452783

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00452783

Key words

Search

Navigation